On February 16th, the FDA published an alert for healthcare professionals regarding safety reports involving the use of compounded intranasal ketamine nasal spray, which could put patients at risk. FDA says they have concerns about increased potential risk of adverse events, misuse, and abuse associated with compounded ketamine nasal spray.
Read More